• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Molecular Pathogenesis of a Dominantly Inherited Disorder-Analysis by Using a Mouse Model of Disorder

Research Project

Project/Area Number 02454494
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Human genetics
Research InstitutionKUMAMOTO UNIVERSITY

Principal Investigator

MAEDA Shuichiro  Kumamoto Univ.School of Medicine, Dept.of Biochemistry, Assoc.Prof., 医学部, 助教授 (10117244)

Co-Investigator(Kenkyū-buntansha) SETOYAMA Chiaki  Kumamoto Univ.School of Medicine, Dept.of Biochemistry, Lecturer, 医学部, 講師 (60040250)
Project Period (FY) 1990 – 1992
KeywordsAmyloidosis / Serum amyloid P component / Mouse model of disorder / Transgenic mouse / Transthyretin / Gene targeting / Familial amyloidotic polyneuropathy / Dominantly inherited disorder
Research Abstract

(1) We examined whether sustained high serum levels of serum amyloid P component (SAP) induced by repeated intraperitoneal injections of E.coli lipopolysaccharide (LPS) enhance the amyloid deposition in the transgenic mouse model of familial amyloidotic polyneuropathy (FAP). No significant difference was detected in the onset, progression, and tissue distribution of amyloid deposition between the LPS-stimulated and unstimulated transgenic mice.
(2) We constructed a sequence replacement vector to introduce an inactivating neo^r marker into the mouse genomic transthyretin (ttr) gene by homologous recombination. The targeting vector consisted of a 5.9 kb DNA fragment derived from the mouse ttr genomic locus and the 1.1 kb neo^r gene from pMC1Neo. A counter-selectable HSV-tk gene was placed at the end of the long region of homology. This vector was electroporated into cultured mouse embryonic stem (ES) cells, which were subsequently selected with G418 and gancyclovir. Among the 132 colonies obtained, 6 homologous recombinants were identified by PCR and Southern blotting.
(3) These ES cells were used to generate chimeric mice by injection into blastocysts. One of these chimeras has shown germline transmission of the disrupted ttr gene. Heterozygous mice were crossed to try to generate homozygotes. Homozygous TTR-deficient mice were found at the expected Mendelian frequencies and appeared to be phenotypically normal. However, levels of serum retinol, retinol-binding protein, and thyroid hormone are significantly depressed in the mutant mice. We are now in the process of establishing transgenic mouse lines carrying the human mutant ttr gene which is responsible for FAP in the homozygous mutant background.

  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Yi,S.et al.: "Systemic amyloidosis in transgenic mice carrying the human mutant transthyretim (Met 30) gene:Pathologic similarlity to human familial amyloidotic polyneuropathy,type I." Am J Pathol. 138. 403-412 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohuchi,K.et al.: "A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain." Biochem Int. 23. 809-817 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tashiro,F.et al.: "Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene." Gerontology. 37(Supple 1). 56-62 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murakami,T.et al.: "Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy." Am J Pathol. 141. 451-456 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murakami,T.et al.: "A novel transthyretin mutation associated with familial amyloidotic polyneuropathy." Biochem Biophys Res Commun. 182. 520-526 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murakami,T.et al.: "A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy." Biochem Biophys Res Commun. 187. 397-403 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Episkopou,V.et al.: "Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone." Proc Natl Acad Sci USA. 90. 2375-2379 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamamura,K.et al.: "Transgenic mouse model for human genetic diseases." Mol Repro Develop. 36. 248-250 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maeda,S.et al.: "in Familial Amiloidotic Polyneuropathy and Other Transthyretin Related Disorders,Molecular structures and evolution of mammalian pentraxin genes." Editions Arquivos de Medicina 3,Porto (Costa,P.P.,de Freitas.A.F.and Saraiva,M.J.M.,eds.), 6 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishiguchi,S.et al.: "in Familial Amiloidotic Polyneuropathy and Other Trans-thyretin Related Disorders,Transcriptional regulation of mammalian pentraxin genes." Editions Arquivos de Medicina 3,Porto(Costa,P.P.,de Freitas.A.F.and Saraiva,M.J.M.,eds), 4 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yi, S.et al.: "Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene : Pathologic similarlity to human familial amyloidotic polyneuropathy, type I" Am J Pathol. 138. 403-412 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohuchi, K.et al.: "A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain" Biochem Int. 23. 809-817 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tashiro, F.et al.: "Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene" Gerontology. 37 (Suppl 1). 56-62 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murakami, T.et al.: "Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy" Am J Pathol. 141. 451-456 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murakami, T.et al.: "A novel transthyretin mutation associated with familial amyloidotic polyneuropathy" Biochem Biophys Res Commun. 182. 520-526 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murakami, T.et al.: "A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy" Biochem Biophys Res Commun. 187. 397-403 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Episkopou, V.et al.: "Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone" Proc Natl Acad Sci USA. 90. 2375-2379 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamamura, K.et al.: "Transgenic mouse model for human genetic diseases" Mol Repro Develop. 36. 248-250 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda, S.et al.: Molecular structures and evolution of mammalian pentraxin genes. in Familial Amiloidotic Polyneuropathy and Other Transthyretin Related Disorders, Editions Arquivos de Medicina 3,215-220 Porto 1990 (Costa, P.P., de Freitas.A.F.and Saraiva, M.J.M., eds.),

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishiguchi, S.et al.: in Familial Amiloidotic Polyneuropathy and Other Transthyretin Related Disorders, Editions Arquivos de Medicina 3,221-224 Porto 1990 (Costa, P.P., de Freitas.A.F.and Saraiva, M.J.M., eds.)25HC02 : Transcriptional regulation of mammalian pentraxin genes,

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi